Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Scientific Reports
|
December 15, 2015
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys
Eric J Smith, Kara Olson, Lauric J Haber, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models
Li Zhang, Carla Castanaro, Bo Luan, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease
John Wityak, Michael E Prime, Frederick A Brookfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2019
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models
John O DaSilva, Katie Yang, Andres E Perez Bay, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease
Michael E Prime, Frederick A Brookfield, Stephen M Courtney, et al.
Plos One
|
March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtin
Wolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Scientific Reports
|
July 13, 2017
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models
Manuel Daldin, Valentina Fodale, Cristina Cariulo, et al.
Cytotherapy
|
December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Science Immunology
|
November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>
Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Scientific Reports
|
December 15, 2015
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys
Eric J Smith, Kara Olson, Lauric J Haber, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models
Li Zhang, Carla Castanaro, Bo Luan, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease
John Wityak, Michael E Prime, Frederick A Brookfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2019
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models
John O DaSilva, Katie Yang, Andres E Perez Bay, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease
Michael E Prime, Frederick A Brookfield, Stephen M Courtney, et al.
Plos One
|
March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtin
Wolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Scientific Reports
|
July 13, 2017
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models
Manuel Daldin, Valentina Fodale, Cristina Cariulo, et al.
Cytotherapy
|
December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Science Immunology
|
November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>
Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Page
of 9